AtriCure, Inc.·4

Mar 7, 7:28 AM ET

Dahlquist Karl S. 4

4 · AtriCure, Inc. · Filed Mar 7, 2024

Insider Transaction Report

Form 4
Period: 2024-03-05
Dahlquist Karl S.
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2024-03-05$37.36/sh8,231$307,51052,839 total
Footnotes (2)
  • [F1]These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.
  • [F2]This transaction was executed in multiple trades at prices ranging from $36.57 to $37.74 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    wk-form4_1709814482.xmlPrimary

    FORM 4